Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Ventura › NPI 1821253402
Clinic

County of Ventura

County of Ventura was paid $4.33M by Medicaid between Jan 2018 and Nov 2019, across 147 billing codes. Its largest line is 0450, Emergency room services — 21% of everything it billed.

33Billing provider infoCOUNTY OF VENTURA
VENTURA, CA 93003
33aNPI1821253402assigned 07/23/2008
33bProvider typeMammography Clinic/Center
28Total paid$4.33M
24GClaims121,154
24DCodes billed147
24AFirst – last monthJan 2018 – Nov 2019
Compared with peers

Next to other Mammography Clinic/Center providers in California

Rank by total paid#1 of 13
Median peer was paid$130K
This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201866,031$2.45M
201955,123$1.88M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 21% 10,344 9,402 $906K
J3490 Unclassified drugs 11% 8,232 4,293 $478K
J7030 Infusion, normal saline solution , 1000 cc 6.5% 1,390 1,305 $283K
A4649 Surgical supply; miscellaneous 5.5% 3,305 1,677 $240K
0360 5.4% 2,085 1,925 $236K
85027 4.5% 8,833 8,131 $193K
81025 3.6% 2,912 2,715 $157K
0160 3.2% 453 260 $139K
J7120 Ringers lactate infusion, up to 1000 cc 2.7% 716 688 $117K
88305 Level IV - Surgical pathology, gross and microscopic examination 2.3% 778 772 $100K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2.3% 489 480 $99K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.6% 421 410 $69K
135 more codes
80053 Comprehensive metabolic panel 1.6% 7,716 $67K
71046 Radiologic examination, chest; 2 views 1.5% 1,338 $66K
87086 Culture, bacterial; quantitative colony count, urine 1.5% 1,699 $65K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.5% 790 $64K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.3% 558 $58K
84443 Thyroid stimulating hormone (TSH) 1.3% 3,544 $58K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 863 $55K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.2% 1,239 $52K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.1% 1,237 $47K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 754 $41K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 116 $41K
83036 Hemoglobin; glycosylated (A1C) <1% 3,662 $39K
0710 <1% 1,754 $38K
81000 <1% 1,945 $33K
80048 Basic metabolic panel (calcium, ionized) <1% 605 $25K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 86 $24K
83721 <1% 2,390 $24K
81002 <1% 352 $22K
83718 <1% 2,478 $21K
73562 <1% 343 $18K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 164 $18K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 278 $17K
84478 <1% 2,634 $16K
70450 Computed tomography, head or brain; without contrast material <1% 366 $15K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 345 $15K
74018 <1% 338 $14K
80069 <1% 166 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 790 $13K
82465 <1% 2,620 $13K
0270 <1% 175 $13K
C1781 Mesh (implantable) <1% 13 $13K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 509 $13K
73610 <1% 227 $13K
86703 <1% 2,108 $12K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 145 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 334 $12K
82746 <1% 667 $11K
73630 <1% 175 $11K
86140 <1% 2,204 $9K
86803 <1% 553 $9K
76830 Ultrasound, transvaginal <1% 166 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 125 $8K
86780 <1% 521 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 57 $7K
73110 <1% 118 $7K
J2704 Injection, propofol, 10 mg <1% 942 $6K
86850 <1% 361 $6K
71045 Radiologic examination, chest; single view <1% 671 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,070 $6K
93975 <1% 45 $5K
84439 <1% 536 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,242 $5K
84702 <1% 191 $5K
87340 <1% 405 $4K
87088 <1% 709 $4K
73130 <1% 55 $4K
81003 <1% 276 $4K
82728 <1% 278 $4K
73030 <1% 67 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,284 $4K
83655 <1% 509 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 481 $4K
82043 <1% 489 $3K
83013 <1% 42 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,555 $3K
86003 <1% 19 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 682 $3K
88304 <1% 300 $3K
87503 <1% 406 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 870 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 619 $3K
85610 <1% 1,079 $2K
84403 <1% 85 $2K
83550 <1% 283 $2K
83540 <1% 312 $2K
86762 <1% 128 $2K
85730 <1% 784 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 18 $2K
85018 <1% 621 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 70 $2K
86480 <1% 25 $2K
73080 <1% 14 $2K
85014 <1% 595 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 81 $2K
85651 <1% 575 $1K
87186 <1% 324 $1K
83735 <1% 2,975 $1K
83880 <1% 191 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 447 $1K
87070 <1% 45 $1K
20610 <1% 41 $1K
73140 <1% 13 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 27 $1K
86901 <1% 398 $1K
83690 <1% 2,887 $1K
86705 <1% 83 $996.68
82550 <1% 912 $941.88
82950 <1% 130 $927.53
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,236 $907.52
86706 <1% 76 $894.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 204 $885.51
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg <1% 28 $880.20
86900 <1% 398 $760.61
82947 <1% 164 $685.44
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 257 $655.86
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 12 $651.02
84153 <1% 29 $619.06
96361 Intravenous infusion, hydration; each additional hour <1% 278 $530.00
86787 <1% 37 $497.96
84481 <1% 25 $463.44
87040 <1% 138 $434.74
86038 <1% 28 $385.09
87081 <1% 52 $356.48
84484 <1% 822 $329.54
J1170 Injection, hydromorphone, up to 4 mg <1% 95 $289.25
81015 <1% 12 $271.16
87205 <1% 109 $262.16
84550 <1% 51 $254.40
80076 <1% 26 $206.13
82785 <1% 20 $205.92
82570 <1% 30 $163.66
85007 <1% 87 $157.53
84100 <1% 46 $93.56
J2780 Injection, ranitidine hydrochloride, 25 mg <1% 13 $82.10
83615 <1% 13 $80.30
85378 <1% 29 $51.12
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 15 $20.97
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 27 $11.02
J2060 Injection, lorazepam, 2 mg <1% 64 $2.70
J7610 Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg 0% 92 $0.00
90715 0% 18 $0.00
82553 0% 17 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 28 $0.00
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 0% 65 $0.00
83605 0% 41 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMILSTIEN, KIM (CHIEF DEPUTY DIRECTOR)